The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells
Abstract Mutations in the tumor suppressor p53 are among the most highly occurring events in colorectal cancer (CRC). Such mutations have been shown to influence the sensitivity of cancer cells to chemotherapeutic agents. However their impact on the efficacy of the proteasomal inhibitor bortezomib r...
Main Authors: | Yasamin Dabiri, Sara Kalman, Clara-Marie Gürth, Jee Young Kim, Viola Mayer, Xinlai Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-05813-z |
Similar Items
-
ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer
by: Javier Rodríguez-Cobos, et al.
Published: (2021-05-01) -
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
by: Alicja Sznarkowska, et al.
Published: (2018-12-01) -
Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
by: Alicja Sznarkowska, et al.
Published: (2019-08-01) -
Role of p53 and Aurora A on G2/M arrest and apoptosis induced by bortezomib in colorectal
by: Wang, Chia-Lin, et al.
Published: (2014) -
CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.
by: Navdeep Malik, et al.
Published: (2021-05-01)